Get started
Author

Jérôme Durivault

Observed names: Durivault, Jerome, Durivault, Jérôme, J Durivault, J. Durivault, Jerome Durivault, Jérome Durivault, Jérôme Durivault (17597595)
Observed institutions: Lyon 1 Université, Centre National de la Recherche Scientifique, Inserm, Université Côte d'Azur, Centre Hospitalier Universitaire de Nice, Institut de Biologie et de Chimie des Protéines, Institut de Biologie Valrose, Scientific Centre of Monaco, Centre Antoine Lacassagne, Université Nice Sophia Antipolis
ORCID: 0000-0002-8228-2915
Observed ORCID: 0000-0002-8228-2915
OpenAlex ID: A5015978447
Double genetic disruption of lactate dehydrogenases A and B is required to ablate the “Warburg effect” restricting tumor growth to oxidative metabolism
2018 · Maša Ždralević, Almut Brand, et al. · Journal of Biological Chemistry · 273
Genetic Disruption of the Multifunctional CD98/LAT1 Complex Demonstrates the Key Role of Essential Amino Acid Transport in the Control of mTORC1 and Tumor Growth
2016 · Yann Cormerais, Sandy Giuliano, et al. · Cancer Research · 216
Genetic Ablation of the Cystine Transporter xCT in PDAC Cells Inhibits mTORC1, Growth, Survival, and Tumor Formation via Nutrient and Oxidative Stresses
2019 · Boutaina Daher, Scott K. Parks, et al. · Cancer Research · 208
The glutamine transporter ASCT2 (SLC1A5) promotes tumor growth independently of the amino acid transporter LAT1 (SLC7A5)
2018 · Yann Cormerais, Pierre André Massard, et al. · Journal of Biological Chemistry · 185
PDF
The HIF-1–Inducible Lysyl Oxidase Activates HIF-1 via the Akt Pathway in a Positive Regulation Loop and Synergizes with HIF-1 in Promoting Tumor Cell Growth
2011 · Floriane Pez, Frédéric Dayan, et al. · Cancer Research · 179
PDF
‘Warburg effect’ controls tumor growth, bacterial, viral infections and immunity – Genetic deconstruction and therapeutic perspectives
2022 · J. Pouysségur, I. Marchiq, et al. · Seminars in Cancer Biology · 178
PDF
Disrupting glucose-6-phosphate isomerase fully suppresses the “Warburg effect” and activates OXPHOS with minimal impact on tumor growth except in hypoxia
2017 · Monique Cunha de Padua, Giulia Delodi, et al. · Oncotarget · 91
PDF
Fas palmitoylation by the palmitoyl acyltransferase DHHC7 regulates Fas stability
2014 · A Rossin, J Durivault, et al. · Cell Death and Differentiation · 86
Acceleration of clear cell renal cell carcinoma growth in mice following bevacizumab/Avastin treatment: the role of CXCL cytokines
2011 · R Grepin, M Guyot, et al. · Oncogene · 85
Genetic disruption of the pHi-regulating proteins Na+/H+ exchanger 1 (SLC9A1) and carbonic anhydrase 9 severely reduces growth of colon cancer cells
2016 · Scott K. Parks, Yann Cormerais, et al. · Oncotarget · 57
PDF
The asparaginyl hydroxylase factor-inhibiting HIF is essential for tumor growth through suppression of the p53–p21 axis
2011 · J Pelletier, F Dayan, et al. · Oncogene · 41
VEGFC acts as a double-edged sword in renal cell carcinoma aggressiveness
2019 · Papa Diogop Ndiaye, Maeva Dufies, et al. · Theranostics · 35
PDF
Targeting the pro-angiogenic forms of VEGF or inhibiting their expression as anti-cancer strategies
2016 · Mélanie Guyot, Caroline Hilmi, et al. · Oncotarget · 34
PDF
Bevacizumab/docetaxel association is more efficient than docetaxel alone in reducing breast and prostate cancer cell growth: A new paradigm for understanding the therapeutic effect of combined treatment
2010 · Cécile Ortholan, Jérôme Durivault, et al. · European Journal of Cancer · 34
The combination of bevacizumab/Avastin and erlotinib/Tarceva is relevant for the treatment of metastatic renal cell carcinoma: the role of a synonymous mutation of the EGFR receptor
2019 · Renaud Grépin, Mélanie Guyot, et al. · Theranostics · 31
PDF
An Evolution-Guided Analysis Reveals a Multi-Signaling Regulation of Fas by Tyrosine Phosphorylation and its Implication in Human Cancers
2016 · Krittalak Chakrabandhu, Sébastien Huault, et al. · PLoS Biology · 30
PDF
A Cystine-Cysteine Intercellular Shuttle Prevents Ferroptosis in xCTKO Pancreatic Ductal Adenocarcinoma Cells
2021 · Willian Meira, Boutaina Daher, et al. · Cancers · 28
PDF
Metabolic Rewiring toward Oxidative Phosphorylation Disrupts Intrinsic Resistance to Ferroptosis of the Colon Adenocarcinoma Cells
2022 · Célia Gotorbe, Jérôme Durivault, et al. · Antioxidants · 26
PDF
Antiangiogenic Compound Axitinib Demonstrates Low Toxicity and Antitumoral Effects against Medulloblastoma
2021 · Marina Pagnuzzi-Boncompagni, Vincent Picco, et al. · Cancers · 20
PDF
Neuropilin 1 and Neuropilin 2 gene invalidation or pharmacological inhibition reveals their relevance for the treatment of metastatic renal cell carcinoma
2021 · Aurore Dumond, Etienne Brachet, et al. · Journal of Experimental & Clinical Cancer Research · 20
PDF
Unveiling CXCR2 as a promising therapeutic target in renal cell carcinoma: exploring the immunotherapeutic paradigm shift through its inhibition by RCT001
2024 · Christopher Montemagno, Arnaud Jacquel, et al. · Journal of Experimental & Clinical Cancer Research · 19
PDF
VEGFC negatively regulates the growth and aggressiveness of medulloblastoma cells
2020 · Manon Penco-Campillo, Yannick Comoglio, et al. · Communications Biology · 19
PDF
Pancreatic Ductal Adenocarcinoma: The Dawn of the Era of Nuclear Medicine?
2021 · Christopher Montemagno, Shamir Cassim, et al. · International Journal of Molecular Sciences · 18
PDF
AKT1 restricts the invasive capacity of head and neck carcinoma cells harboring a constitutively active PI3 kinase activity
2018 · Sanja Brolih, Scott K. Parks, et al. · BMC Cancer · 18
PDF
Carbonic anhydrase XII expression is linked to suppression of Sonic hedgehog ligand expression in triple negative breast cancer cells
2019 · G. Guerrini, J. Durivault, et al. · Biochemical and Biophysical Research Communications · 15
Works count: 146
Citation count: 2,015
H-index: 20
I10-index: 27
Year
Topic
Type